SREBF2 and fatty liver disease: For instance, hepatitis C virus genes have been proven to alter host cell cholesterol/lipid metabolism by stimulating the phosphorylation of SREBPs and proteolytic processing of SREBP2, thus inducing hepatic steatosis [57, 58].